2026 Excellence Award for Hypertension Research Lecturer – Gregory Fink, PHD, FAHA

Gregory C Fink, PHD, FAHA

Michigan State University
East Lansing, Michigan

Gregory Fink, PhD, is a full professor in the Department of Pharmacology and Toxicology at Michigan State University, where he has served since 1977.

Fink received his PhD in pharmacology and toxicology from Tulane University in 1975. He did postdoctoral work at the University of Iowa from 1975 to 1977, where his research focused on neural control of circulation in hypertension.

His research continues to focus on sympathetic mechanisms of blood pressure regulation in hypertension. Other important interests include the renin-angiotensin system, endothelin and the role of venous function and body fluid volume distribution in control of blood pressure. More recently, his work has focused on the causes of obesity-related cardiovascular disease. He has published over 250 peer-reviewed papers on hypertension. Throughout his career, he has served on the editorial boards of numerous journals that publish cardiovascular science and has been an active member of the American Heart Association Council on Hypertension, including a two-year term as chair.

His research awards include the Arthur C. Corcoran Memorial Lecture, Council for High Blood Pressure Research, American Heart Association (2008); the Council on Hypertension Distinguished Achievement Award, American Heart Association (2017); and the Irvine Page and Alva Bradley Lifetime Achievement Award, Council on Hypertension, American Heart Association (2017).